Format

Send to:

Choose Destination
See comment in PubMed Commons below
Eur J Cancer. 2007 Dec;43(18):2638-44. Epub 2007 Oct 31.

Medicinal cannabis in oncology.

Author information

  • 1Erasmus University Medical Centre--Daniel den Hoed Cancer Centre, Department of Medical Oncology, Groene Hilledijk 301, 3075 EA, Rotterdam, The Netherlands.

Abstract

In The Netherlands, since September 2003, a legal medicinal cannabis product, constituting the whole range of cannabinoids, is available for clinical research, drug development strategies, and on prescription for patients. To date, this policy, initiated by the Dutch Government, has not yet led to the desired outcome; the amount of initiated clinical research is less than expected and only a minority of patients resorts to the legal product. This review aims to discuss the background for the introduction of legal medicinal cannabis in The Netherlands, the past years of Dutch clinical experience in oncology practice, possible reasons underlying the current outcome, and future perspectives.

PMID:
17976975
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk